Entity Wide Disclosures (Tables)

9 Months Ended

Sep. 30, 2019

Entity Wide Disclosures [Abstract]

Summary of Revenue by Major Source

The following table disaggregates our revenue by major source (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2019		2018		2019		2018
Therapeutic Area
Oncology	$	65,529	$	48,947	$	186,152	$	135,824
Other		53,484		42,200		158,676		114,852
Metabolic		34,919		30,037		102,287		90,748
AVAI		24,243		21,947		66,831		59,497
Cardiology		21,733		22,227		68,792		71,262
Central Nervous System		16,330		13,895		48,345		40,291
Total revenue	$	216,238	$	179,253	$	631,083	$	512,474